Related Experiment Video
Updated: Jan 14, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Recent innovations and challenges in the treatment of fungal infections
Di Liu1, Renjie Zhou1, Xindi Gao1
1Department of Emergency, Xinqiao Hospital, Army Medical University, Chongqing, China.
Abstract:
The prevalence of fungal infections has been increasing consistently in recent years, particularly among immunocompromised individuals, resulting in increased mortality. The World Health Organization (WHO) now lists "super fungi", such as Candida auris as global public health threats, highlighting the urgent requirement for new antifungal therapies. Although conventional agents such as azoles and polyenes remain prevalent in medical treatment, challenges including drug resistance, limited selectivity, and high toxicity limit their value, prompting the need for the development of more effective therapeutic strategies. Current research trends are shifting towards multi-mechanistic combination therapies and biotechnology-driven approaches, which demonstrate significant potential. This review summarizes recent advances and outlines directions for future antifungal drug development and new therapies.
Insights
Rising fungal infections and drug resistance necessitate novel antifungal therapies. This review explores innovative strategies, including combination treatments and biotechnological approaches, to combat "super fungi" like Candida auris.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Drug Discovery
Background:
- Increasing prevalence of fungal infections, especially in immunocompromised populations.
- Emergence of drug-resistant fungal strains, including WHO-designated "super fungi" like Candida auris.
- Limitations of current antifungal agents (azoles, polyenes) due to resistance, toxicity, and selectivity issues.
Purpose of the Study:
- To review recent advancements in antifungal drug development.
- To outline future directions for novel antifungal therapies.
- To address the urgent need for effective treatments against resistant fungal pathogens.
Main Methods:
- Literature review of current research trends in antifungal therapy.
- Analysis of emerging strategies such as multi-mechanistic combination therapies.
- Evaluation of biotechnology-driven approaches for antifungal drug development.
Main Results:
- Identification of multi-mechanistic combination therapies as a promising strategy.
- Highlighting the potential of biotechnology-driven approaches in overcoming resistance.
- Summarizing key challenges and opportunities in the field.
Conclusions:
- Novel antifungal therapies are urgently required due to rising infections and resistance.
- Combination therapies and biotechnological innovations show significant potential for future treatments.
- Continued research and development are crucial for combating global fungal threats.
Related Concept Videos
Fungal Phylum Microsporidia
Microorganisms in Medicine and Therapeutics
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drug Therapy
Antianxiety Medications
Overview of Fungi

